PRKAA2 and cancer: Transient activation of AMPK, in response to ATP depletion, was found to be an additional predictor of cancer cell sensitivity to apoptolidin A; representative human glioblastoma and lung cancer cells with an oxidative metabolic phenotype showing robust changes in AMPK stress signaling, whereas more glycolytic cell types lacked this response [25].